The recall was originally announced Sept. 6 by the Centers for Disease Control and Prevention. It was upgraded Sept. 30 to ...
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
Special to the OBSERVER OAKLAND, Calif. (KFF) — The patient was in his 60s, an African American man with emphysema.
The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...
Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Pfizer has announced the approval of HYMPAVZI by the US Food and Drug Administration (FDA) for patients with haemophilia A ...
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...